I was wondering the other day why I had not received a notice of...

I was wondering the other day why I had not received a notice of meeting for the ACL AGM, so I rang the share registry and got a new one sent out. I did this because I wanted to send a strong message to the current board of directors about how they have handled the company post the phase III failure. For me this is getting personal.
Failures in clinical trials happen, I accept that. That is the educated risk we all took when we bought in to ACL. I have no problem with a technical failure.
Since then we have been told that there were potentially inconsistencies with some of the trial sites. OK – if that’s the case why didn’t we look to partner or run a second and better trial?
My issue is this, and my message to the board is this – if you don’t have the courage to run another trial yourselves why don’t you sell the asset or even give it back to the inventor. At least she has the drive to try and make something of it. The board of ACL have been telling us for some time that they are seeking potential partners and speaking to potential licensees – I call bull.
If the board were serious about partnering or licensing or even selling the whole kit and caboodle they would not let their most valuable asset, their IP lapse quietly without comment. I say this and I can prove it.
In the 2013 annual report, and the 2014 annual report there are lists of Alchemia Oncology IP. Take for example Australian Patent 773984 – fees were not paid on 6^th January 2016 and the patent lapsed. You can verify this yourself by going to www.ipaustralia.gov.au clicking on search patents and putting in the patent number above. Try it for 2004279475 – fees not paid 11 October 2016, or 2007233549 – fees not paid 23 March 2016, or 2006289651 – fees not paid 4 September 2016
These are just a few of many that have been allowed to lapse in Australia, Europe and the USA. There is precious little left to sell or even give away. The directors have undermined any value that remained. And as to the tax credits – they are also worthless. Any newco will not be able to meet the continuity of business test at this point in time, whereas a further development of HA-I would certainly have qualified.
Well, enough of my ranting – however you feel about the above – please VOTE on the reappointment of directors for ACL - you can vote online.